Adverse neonatal effects of maternal labetalol treatment

B. N.A. Crooks; S. A. Deshpande; C. Hall; M. P. Ward Platt; D. W.A. Milligan

doi:10.1136/fn.79.2.F150

Adverse neonatal effects of maternal labetalol treatment

B. N.A. Crooks, S. A. Deshpande, C. Hall, M. P. Ward Platt, D. W.A. Milligan

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

23 Citas (Scopus)

Resumen

Two infants with features of severe β adrenergic blockade, pericardial effusions, and myocardial hypertrophy were born to mothers receiving long term treatment with oral labetalol for hypertension in pregnancy. Labetalol was implicated in the aetiology of these problems. Pericardial effusion and myocardial hypertrophy have not been associated with labetalol toxicity in neonates.

Idioma original	English
Páginas (desde-hasta)	F150-F151
Publicación	Archives of Disease in Childhood: Fetal and Neonatal Edition
Volumen	79
N.º	2
DOI	https://doi.org/10.1136/fn.79.2.F150
Estado	Published - 1998
Publicado de forma externa	Sí

ASJC Scopus Subject Areas

Pediatrics, Perinatology, and Child Health
Obstetrics and Gynaecology

Acceder al documento

10.1136/fn.79.2.F150

Otros archivos y enlaces

Citar esto

@article{deabb66c6ea34a049ac36be430ec6b19,

title = "Adverse neonatal effects of maternal labetalol treatment",

abstract = "Two infants with features of severe β adrenergic blockade, pericardial effusions, and myocardial hypertrophy were born to mothers receiving long term treatment with oral labetalol for hypertension in pregnancy. Labetalol was implicated in the aetiology of these problems. Pericardial effusion and myocardial hypertrophy have not been associated with labetalol toxicity in neonates.",

author = "Crooks, {B. N.A.} and Deshpande, {S. A.} and C. Hall and {Ward Platt}, {M. P.} and Milligan, {D. W.A.}",

year = "1998",

doi = "10.1136/fn.79.2.F150",

language = "English",

volume = "79",

pages = "F150--F151",

journal = "Archives of Disease in Childhood: Fetal and Neonatal Edition",

issn = "1359-2998",

publisher = "BMJ Publishing Group",

number = "2",

}

TY - JOUR

T1 - Adverse neonatal effects of maternal labetalol treatment

AU - Crooks, B. N.A.

AU - Deshpande, S. A.

AU - Hall, C.

AU - Ward Platt, M. P.

AU - Milligan, D. W.A.

PY - 1998

Y1 - 1998

N2 - Two infants with features of severe β adrenergic blockade, pericardial effusions, and myocardial hypertrophy were born to mothers receiving long term treatment with oral labetalol for hypertension in pregnancy. Labetalol was implicated in the aetiology of these problems. Pericardial effusion and myocardial hypertrophy have not been associated with labetalol toxicity in neonates.

AB - Two infants with features of severe β adrenergic blockade, pericardial effusions, and myocardial hypertrophy were born to mothers receiving long term treatment with oral labetalol for hypertension in pregnancy. Labetalol was implicated in the aetiology of these problems. Pericardial effusion and myocardial hypertrophy have not been associated with labetalol toxicity in neonates.

UR - http://www.scopus.com/inward/record.url?scp=0031683929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031683929&partnerID=8YFLogxK

U2 - 10.1136/fn.79.2.F150

DO - 10.1136/fn.79.2.F150

M3 - Article

AN - SCOPUS:0031683929

SN - 1359-2998

VL - 79

SP - F150-F151

JO - Archives of Disease in Childhood: Fetal and Neonatal Edition

JF - Archives of Disease in Childhood: Fetal and Neonatal Edition

IS - 2

ER -

Adverse neonatal effects of maternal labetalol treatment

Resumen

ASJC Scopus Subject Areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto